Hims' Andrew Dudum: A DTC shake out is coming

One year old men's healthcare DTC brand is attempting to disrupt healthcare. The company, which is centered around removing the friction from treating common health issues such as erectile disfunction and hair loss, uses a combination of affordable product lines and education in an attempt to get men talking more freely about their health. They're also trying to branch out beyond men: Hims has also launched a female-focused counterpart, appropriately titled Hers, hopes to solve this issue of access to birth control and time spent waiting in line at the pharmacy. The products, paired with the opportunity to have 24-hour access to physicians, have helped Hims to raise about $100 million in funding, and, if the rumors are true, of a new round of funding may just raise the valuation to a whopping $1 billion. On this week's episode of Making Marketing, Shareen Pathak sits down with Hims founder and CEO, Andrew Dudum, to discuss using humor as a marketing strategy for touchy topics, the impending DTC bubble burst and making the move into female wellness.